Literature DB >> 2684448

Effects of inhibition of fatty acid oxidation on myocardial kinetics of 11C-labeled palmitate.

W Wyns1, M Schwaiger, S C Huang, D B Buxton, H Hansen, C Selin, R Keen, M E Phelps, H R Schelbert.   

Abstract

The effects of glucose and lactate infusion on palmitate oxidation were compared with the effect of 2-tetradecylglycidic acid (TDGA), an irreversible inhibitor of the carnitine acyltransferase I, in normoxic canine myocardium. The initial capillary transit retention fraction of [1-11C]palmitate and its fractional distribution between oxidation and esterification in myocardium were measured by the residue detection method after intracoronary tracer injection, as well as by effluent measurements of 11CO2, the end product of palmitate oxidation. TDGA reduced the initial capillary transit retention fraction (from 56 +/- 13% to 37 +/- 6%; p less than 0.001) and oxidation of palmitate (n = 19), as also evidenced by the decrease in the fraction of tracer released as 11CO2 from 28 +/- 5% to 6 +/- 3% (p less than 0.001). Infusion of carbohydrate (glucose or lactate; n = 6) reduced 11CO2 production from 30 +/- 7% to 7 +/- 4% (p less than 0.05) but did not alter the initial capillary transit retention fraction of tracer (59 +/- 5% vs. 56 +/- 10%; NS). The latter was due to increased esterification into neutral lipids (41 +/- 11% of injected palmitate after carbohydrate infusion versus 21 +/- 12% in control conditions), as measured from multiexponential curve fittings. When carbohydrates were given after inhibition of palmitate oxidation by TDGA (n = 7), the 11C tissue clearance kinetics were strikingly similar to those observed after carbohydrate infusion alone. Thus, enhanced metabolic trapping of [1-11C]palmitate in myocardium resulted in initial capillary transit retention fractions that were not different from control conditions (41 +/- 5% vs. 48 +/- 12%; NS) despite inhibition of oxidation. The results show that the intracellular metabolism of palmitate contributes to the control of its uptake by myocardium. The findings are consistent with inhibition of palmitate oxidation by carbohydrates occurring at the same site as TDGA.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2684448     DOI: 10.1161/01.res.65.6.1787

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  7 in total

Review 1.  Tracers for metabolic imaging of brain and heart. Radiochemistry and radiopharmacology.

Authors:  G Stöcklin
Journal:  Eur J Nucl Med       Date:  1992

Review 2.  Radionuclide assessment of myocardial fatty acid metabolism by PET and SPECT.

Authors:  N Tamaki; Y Fujibayashi; Y Magata; Y Yonekura; J Konishi
Journal:  J Nucl Cardiol       Date:  1995 May-Jun       Impact factor: 5.952

3.  Correlation of heterogeneous blood flow and fatty acid uptake in the normal dog heart.

Authors:  A B Groeneveld; F C Visser
Journal:  Basic Res Cardiol       Date:  1993 May-Jun       Impact factor: 17.165

4.  The effect of methyl palmoxirate on incorporation of [U-14C]palmitate into rat brain.

Authors:  M C Chang; S Wakabayashi; J M Bell
Journal:  Neurochem Res       Date:  1994-09       Impact factor: 3.996

Review 5.  Interrelationship between lactate and cardiac fatty acid metabolism.

Authors:  G J van der Vusse; M J de Groot
Journal:  Mol Cell Biochem       Date:  1992-10-21       Impact factor: 3.396

6.  Mechanism of the diastolic dysfunction induced by glycolytic inhibition. Does adenosine triphosphate derived from glycolysis play a favored role in cellular Ca2+ homeostasis in ferret myocardium?

Authors:  H Kusuoka; E Marban
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

Review 7.  PET Metabolic Biomarkers for Cancer.

Authors:  Etienne Croteau; Jennifer M Renaud; Marie Anne Richard; Terrence D Ruddy; François Bénard; Robert A deKemp
Journal:  Biomark Cancer       Date:  2016-09-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.